Citation:Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR 2002

From Cancer Guidelines Wiki

Citation


Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg 2002 Mar;21(3):520-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11888774.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR 2002Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?Associate Professor Gavin Wright MD FRACS PhDcompleted
Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR 2002 2Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?Associate Professor Gavin Wright MD FRACS PhDcompleted
Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR 2002 3What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?Associate Professor Gavin Wright MD FRACS PhDcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage I NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Does complete mediastinal lymph node dissection improve overall survival compared to mediastinal lymph node staging in stage II NSCLC?
  2. What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Passlick_B,_Kubuschock_B,_Sienel_W,_Thetter_O,_Pantel_K,_Izbicki_JR_2002&oldid=20848"